Episodios

  • S13: #116: Empowering Women's Health through Access to Contraception in Low/Middle Income Countries

    S13: #116: Empowering Women's Health through Access to Contraception in Low/Middle Income Countries
    Sep 26 2023
    Women and girls in low/middle-income countries are facing an urgent unmet need for modern contraception. This World Contraception Day, join guest host Sophie Park, Managing Director at G4A Digital Health Bayer in conversation with Dr. Ariane de Hoog, Lead Access to Medicine, Community Engagement at Bayer, and Titilola Olaolu-Hassan, Co-Founder & COO at Zuri Health, for this vital discussion on harnessing digital health solutions to empower women and enhance healthcare accessibility in Africa. Topics include: [00:02:14] Background to Bayer’s interest in empowering Women’s health. [00:05:05] Zuri Health: Affordable healthcare for underserved communities. [00:06:28] Impact goals behind Zuri becoming a G4A Portfolio company. [00:11:37] How the Zuri Health platform directly improves girls' and women's access to healthcare. [00:14:08] The future beyond family planning for Zuri Health in partnership with Bayer. [00:15:53] Bayer’s impact goal to provide 100 million women access to modern contraception by 2030. [00:20:23] Empowering women to make informed decisions irrespective of location Guest & Host Links Connect with Dan Kendall on LinkedIn Connect with Sophie Park on LinkedIn Connect with Dr. Ariane de Hoog on LinkedIn Connect with Titilola Olaolu-Hassan on LinkedIn Bayer G4A Zuri Health - Your-Life website - complimentary access to an array of educational and training resources on adolescent health and contraceptive counselling Digital Health Today would not be possible without the support of leading organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: LSI | Lindus Health | Bayer G4A Connect on Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    25 m
  • S13: #115: CancerX Initiative Aims to Reduce Cancer Deaths by 50% by 2047

    S13: #115: CancerX Initiative Aims to Reduce Cancer Deaths by 50% by 2047
    Mar 30 2023
    The Digital Medicine Society (DiMe) and Moffitt Cancer Center have announced they are co-hosting CancerX, a new public-private partnership effort to rapidly accelerate the pace of cancer innovation in the U.S. Alongside the Office of the National Coordinator for Health Information Technology (ONC) and the Office of the Assistant Secretary for Health (OASH), Moffitt Cancer Center and DiMe are urging the healthcare and digital health sectors to boost technology-driven initiatives to combat cancer. The two groups are working together to accelerate cancer research advancements, and they invite other organizations to do the same. The Biden administration's revived Cancer Moonshot includes the new CancerX public-private partnership. According to officials, the goal is to use industry collaboration and disruptive innovation to lessen the burden of cancer on everyone. The CancerX program will focus on using digital innovation to reduce disparities and financial toxicity in cancer care and research, working with government organizations, and will enlist industry parties to help with the mammoth undertaking. CancerX uniquely blends DiMe’s expertise in convening cross-disciplinary groups to develop clinical-quality resources on a tech timeline with Moffitt’s top research and care experts working side-by-side to revolutionize cancer treatment, extend access to the highest-quality care, and save more lives. The initiative is open to all those working in the field who are committed to working collaboratively and share a vision of unleashing the power of innovation to design and create a future that's free of the burden of cancer. Topics include: What is the Digital Medicine Society? Announcing CancerX, key initiatives and membership structure Improving the global ecosystem Guest & Host Links Connect with Dan Kendall | LinkedIn Connect with Jennifer Goldsack | LinkedIn and listen to her episode from May 2019 CancerX Digital Medicine Society Dime Academy DiMe Society Slack Digital Health Today would not be possible without the support of leading organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: Akili | Lindus Health | Bayer G4A Connect on Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    11 m
  • Coffee Talk: Implementing Solutions for Health Systems with AmalgamRX

    Coffee Talk: Implementing Solutions for Health Systems with AmalgamRX
    Dec 21 2022
    In this coffee talk with AmalgamRX we dive into the challenges being faced by health systems as they work to assess, develop, and implement solutions at the time of a clinical decision. We'll explore the major pain points that keep projects from reaching their full potential, what it takes to overcome these challenges and what you can do when you're developing a digital therapeutic solution for your organization. There's also some tips that apply to payers and pharma as they play a key role in the successful development and implementation of digital therapies. Guest Links and Resources: Connect with Jenni Main on LinkedIn Connect with Dr. Suzanne Clough on LinkedIn Visit https://amalgamrx.com/ Host Links: Connect with Dan Kendall: Twitter | LinkedIn Connect with Eugene Borukhovich: Twitter | LinkedIn Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    24 m
  • Guest Host: The Progress and Promise of Predicting Complications in Pregnancy

    Guest Host: The Progress and Promise of Predicting Complications in Pregnancy
    Jul 12 2022
    I’m glad to be back on the mic and bringing you this special episode of Digital Health Today 360. Why is this episode special? Let me explain. One of the goals of the Digital Health Today channel is to create a space where people can learn about great innovation that can improve the health of both individuals and entire populations. Over the years, as I’ve been creating my own show, I’ve also had the opportunity to expand and serve the health community in other ways. Along with my colleagues at Mission Based Media, we’ve created other audio-first resources to share more information. For example, we created Health Podcast Network to showcase other high-quality, human-centered and evidence-based podcasts. Health Podcast Network now has about 100 different health podcasts and 13,000 episodes. We also worked through the pandemic to add new shows to Digital Health Today such as the DTx Podcast with Eugene Borukhovich, where he dives into the nascent digital therapeutics industry. And, most recently, we launched a library of podcasts called Health Unmuted where we create and share short-format, narrated, audio stories to help people understand more about specific health conditions. We launched the proof-of-concept miniseries last year called COPD Podcast. In June we launched the 5-part miniseries about Alzheimer’s Disease, and this month, in July, we’ll launch a 7-part miniseries about Parkinson’s disease. Why am I explaining all this? Because all this work at the intersection of health and podcasting has given me a chance to experiment with different formats, styles, content and audiences, and it’s also made me realize that I love creating this show. It’s also made me more aware than ever that there is so much more that needs to be shared. So, in this special episode, as I fire up the recording studio and prepare some great conversations with guests over the coming weeks and months, I thought I’d stand aside and invite another podcaster who is doing some great work in an area that needs much more attention. Georgie Kovacs is the founder and host of Fempower Health - the go-to resource for all things women’s health serving women, their providers, and companies looking to build and improve on products for women. Georgie is really open about her first-hand experience with infertility and endometriosis. With that experience, she was motivated to start a podcast - in the middle of COVID, and as a single parent. Now if that’s not passion, I don’t know what is. You can find her show, Fempower Health, on Health Podcast Network. In this special episode, Georgie spoke with Dr. Michal Elovitz. Dr. Elovitz is the Distinguished Professor in Women’s Health at the Perelman School of Medicine at the University of Pennsylvania and she’s also the Chief Medical Advisor at Mirvie, a company creating a personalized window into pregnancy health. When it comes to women’s health, I’ve been astonished at the tremendous need for improvement, funding and resources, and at the same time, I’ve also seen some incredible innovation that is happening that needs more attention, awareness and funding! And despite the U.S. having the highest maternal mortality rate among developed countries, health risks in pregnancy health have remained understudied, underfunded, and underserved. Pregnancy complications such as preeclampsia, preterm birth and gestational diabetes impact 1 in 5 women, and with no accurate way to predict them before symptoms appear, both moms and babies are often in crisis mode when diagnosed in their third trimester. In their conversation, Georgie and Dr. Elovitz explain one of those complications, preeclampsia, and explore how better screening can help. Let me know what you think of this episode. Drop me a line on Twitter or LinkedIn and let me know! More great episodes of DHT360 are on the way, so be sure to hit follow on your favorite podcast app. Thanks for tuning in! Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    24 m
  • S12: #114: Who's Responsible for Ethical Decision Making? Promoting Trust in Technology and Healthcare

    S12: #114: Who's Responsible for Ethical Decision Making? Promoting Trust in Technology and Healthcare
    Dec 1 2021
    Technology is under the microscope, as are the behaviors of the people who develop and deploy it. As technology impacts virtually every aspect of society, it's use within the life sciences goes beyond traditional bioethical topics. This creates a host of questions for people and businesses working at the forefront of health innovation. In this episode, hear Nick Bott, Global Head, Bioethics and Technology Ethics at Takeda as we discuss: What is being done to ensure that the decisions around the use of technology for our health and wellbeing are carefully considered and applied? Whose job is it to address the ethical questions in the development of AI and ML algorithms? How can life science companies lead the way in setting standards for ethical development? What can we learn from Tony Stark - otherwise known as Iron Man in the Marvel Cinematic Universe? What is a 'consequence scanning workshop'? What is the role of regulation in setting standards and principles? Episode Links and Resources: Learn More About Ethics and Compliance at Takeda Notre Dame-IBM Technology Ethics Lab Markkula Center for Applied Ethics at Santa Clara University About the Age of Ultron - a lesson in 'irresponsible innovation'? Hear the Coffee Talk about the Health Outcomes Observatory (H2O) Guest Host Links Connect with Nick Bott on LinkedIn Connect on Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Roche Takeda Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    28 m
  • S12: #113: Jane Sarasohn-Kahn on Women's Health, Social Determinants of Health, and the 'She-cession'

    S12: #113: Jane Sarasohn-Kahn on Women's Health, Social Determinants of Health, and the 'She-cession'
    Aug 19 2021
    Guest host Sophie Park interviews health economist Jane Sarasohn-Kahn for this fast-paced discussion about women's health, social determinants of health and the 'she-cession' in the wake of the COVID-19 pandemic. We've seen the headlines during COVID-19: Rising caseloads. Millions of lives lost. Economic devastation. Schools closed. But these only tell part of the story. The impact of the pandemic on mental and physical health extends far beyond those that are directly infected with the disease. Delayed diagnosis, canceled or delayed treatment, loss of employment and the collision of home and professional responsibilities has had a tremendous and long-lasting impact. Join Jane Sarasohn-Kahn and guest host Sophie Park in this discussion about the affects of the pandemic. For more discussion about women's health, check out the video panel with Jane and Sonia Millsom, Chief Commercial Officer of Maven Clinic, on the September 9 Digital Health Forum. Episode Links and Resources: Connect with Jane Sarasohn-Kahn: Website | Twitter | LinkedIn | Attend Digital Health Forum: Website | LinkedIn | Twitter Tune into Episode 16 with Kate Ryder, founder of Maven Clinic Guest Host Links Twitter @sophiemariepark Linkedin: https://www.linkedin.com/in/sophiemariepark/ Connect on Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Roche Takeda Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    28 m
  • Coffee Talk: H2O - How the Health Outcomes Observatory Gives Patients Better Tools and Bigger Voices

    Coffee Talk: H2O - How the Health Outcomes Observatory Gives Patients Better Tools and Bigger Voices
    Aug 3 2021
    Every day, tech companies and governments frame the conversation around the use of data. With the proliferation of smartphones and wearable devices, online shopping, and home voice assistants, we leave a digital footprint with almost everything we do. While our data can be crunched to drive better insights on listening habits, activity levels, and consumer preferences. There's also a far more important application for our data: to improve human lives and health outcomes. In this coffee talk, we explore how leaders in the pharmaceutical industry are working with people, policy makers and providers to create solutions that will usher in a new era of healthcare solutions and services. This Coffee Talk is created with support from Takeda. Guest Links and Resources: Connect with Meni Styliadou: LinkedIn Connect with Takeda: Website | Twitter | LinkedIn Connect with H2O: Website | Twitter | LinkedIn | YouTube European Patient Forum: Website Innovative Medicines Initiative: Website | Twitter | LinkedIn | YouTube Host Links Connect with Dan: Twitter | LinkedIn Connect on Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    16 m
  • Coffee Talk: Why is Digital Health Important to Biopharmaceutical Companies?

    Coffee Talk: Why is Digital Health Important to Biopharmaceutical Companies?
    Jun 11 2021
    The pandemic has illustrated how Social Determinants of Health (SDOH) can impact the spread of disease, access to vaccines and the levels of trust in and utilization of basic health services. Beyond the focus on SDOH by politicians, advocacy, groups, and charitable organizations, there are private and public commercial organizations that make it a priority to find and fund solutions that address the social and cultural barriers that reduce or limit access to care. One of those organizations is Bayer. In this conversation with Dominick Kennerson, Global Head of Bayer G4A, we discuss how equity, access and sustainability help set the course for their investment strategy. This Coffee Talk is created in partnership with our Sponsor, Bayer G4A. This year Bayer G4A is looking for companies creating solutions to 5 key challenges including oncology, radiology, mental health, women's health and cardio metabolic and renal diseases. The Bayer G4A program is open to companies from pre-seed stage to Series A, and even more advanced companies with traction in the market. Apply to be a part of Bayer G4A here, and tell them you heard about it on Digital Health Today. The deadline to apply is June 20, 2021. Guest Links and Resources: Connect with Dom Kennerson: Twitter | LinkedIn Connect with Bayer G4A: Website | Twitter | LinkedIn | YouTube World Health Organization - Website | Constitution Host Links Connect with Dan: Twitter | Linkedin Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    13 m
adbl_web_global_use_to_activate_webcro768_stickypopup